Sun Pharmaceutical Industries Limited Announced That It Has Received Final Approval From Us Fda For Its Abbreviated New Drug Application (Anda) For Generic Mesalamine Extended Release Capsules, 500 Mg. The Generic Product Approval Is Based On Pentasa Extended Release Capsules, 500Mg As A Reference Product. As Per March 2022 Iqvia Health Data, Pentasa Extended Release Capsules, 500Mg Had Annualized Sales Of Approximately Us$ 213 Million In Usa. Sun Pharma Is The World'S Fourth Largest Specialty Generic Pharmaceutical Company And India'S Top Pharmaceutical Company.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!